Cumulative life course impairment: identifying patients at risk.
about
Psoriasis: to treat or to manage?Quality of life in psoriasis patients.Barriers to guideline-compliant psoriasis care: analyses and concepts.Moderate to severe psoriasis patients' subjective future expectations regarding health-related quality of life and longevity.Assessing the overall benefit of a medication: cumulative benefit of secukinumab over time in patients with moderate-to-severe plaque psoriasis.Impact of psoriasis severity on family income and quality of life.
P2860
Cumulative life course impairment: identifying patients at risk.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Cumulative life course impairment: identifying patients at risk.
@en
Cumulative life course impairment: identifying patients at risk.
@nl
type
label
Cumulative life course impairment: identifying patients at risk.
@en
Cumulative life course impairment: identifying patients at risk.
@nl
prefLabel
Cumulative life course impairment: identifying patients at risk.
@en
Cumulative life course impairment: identifying patients at risk.
@nl
P356
P1476
Cumulative life course impairment: identifying patients at risk.
@en
P2093
Matthias Augustin
P356
10.1159/000350555
P577
2013-05-30T00:00:00Z